KALOUN, EL BACHIR,BEDJEGUELAL, KARIM,RABOT, RÉMI,KRUCZYNSKI, ANNA,SCHMITT, PHILIPPE,PEREZ, MICHEL,RAHIER, NICOLAS
申请号：
TN2013000293
公开号：
TN2013000293A1
申请日:
2013.07.11
申请国别(地区):
TN
年份:
2015
代理人:
摘要：
The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture； as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease； to the use of same as a kinase inhibitor； to the pharmaceutical compositions comprising same； and to methods for the preparation of same.
